Original Source Material
AI Rebuilds $50B Pharma Giant's Thinking, Plan Could Help Every Data-Driven Firm GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms accelerate hypothesis generation, imaging analysis and drug discovery workflows, offering CIOs a blueprint for enterprise-scale AI transformation in regulated industries.